Indian drugmakers get regulatory nod to sell generic Wegovy, heating obesity‑drug race

Data ​on the regulator’s website show Zydus Lifesciences and Alkem Laboratories received approval last week to manufacture and sell generic semaglutide for weight-loss and diabetes treatment